Gastric mucosal damage by anti-inflammatory drugs.
D000042:Absorption; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism; D004058:Diffusion; D005752:Gastric Mucins / Q000378:metabolism; D005753:Gastric Mucosa / Q000187:drug effects* / Q000378:metabolism; D005756:Gastritis / Q000139:chemically induced; D006471:Gastrointestinal Hemorrhage / Q000628:therapy; D006801:Humans; D006859:Hydrogen / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D007213:Indomethacin / Q000009:adverse effects; D010653:Phenylbutazone / Q000009:adverse effects; D013276:Stomach Ulcer / Q000139:chemically induced; D013608:Tablets, Enteric-Coated
D000893:Anti-Inflammatory Agents; D005752:Gastric Mucins; D013608:Tablets, Enteric-Coated; D006859:Hydrogen; D010653:Phenylbutazone; D001241:Aspirin; D007213:Indomethacin